HealthQuill Amplifica Holdings Group Inc
Amplifica Holdings Group Inc.’s first-in-human trial of an injectable medicine for treating hair loss has shown a more than 15% increase in non-vellus hair count, sustained hair density and thickness over time.
Drugs Health Pharma

Amplifica’s human trial medicine for hair growth shows 15% more efficacy

Amplifica Holdings Group Inc.’s first-in-human trial of an injectable medicine for treating hair loss has shown a more than 15% increase in non-vellus.

Read More